Early randomized trials of the addition of neoadjuvant chemotherapy (NACT) to the
treatment regimen of patients with breast cancer failed to demonstrate an improvement in …

Objectives This systematic review aimed to assess the role of magnetic resonance imaging
(MRI) in evaluating residual disease extent and the ability to detect pathologic complete …

Neoadjuvant therapy is increasingly being used to treat early-stage triple-negative and
human epidermal growth factor 2–overexpressing breast cancers, as well as locally …

In oncology, staging forms the basis for prognostic consideration and directly influences
patient care by determining the therapeutic approach. Cross-sectional imaging techniques …

Objectives To enhance the accurate prediction of the response to neoadjuvant
chemotherapy (NAC) in breast cancer patients by using a quantitative analysis of dynamic …

Background Early prediction of treatment response to neoadjuvant chemotherapy (NACT) in
patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer can …

Purpose To present a method for identifying intrinsic imaging phenotypes in breast cancer
tumors and to investigate their association with prognostic gene expression profiles …

OBJECTIVE. The objective of our study was to determine the accuracy of preoperative
measurements for detecting pathologic complete response (CR) and assessing residual …

Background In the setting where determining extent of residual disease is key for surgical
planning after neoadjuvant chemotherapy (NAC), we evaluate the reliability of MRI in …

Breast cancer imaging phenotype is diverse and may relate to molecular alterations driving
cancer behavior. We systematically reviewed and meta-analyzed relations between breast …